RxDoctor Payments DataLook up a doctor →

Alexander Ryan, DO

Internal Medicine · Lincoln, NENPI 1912319344

Payments from drug & device makers

$2,153,333in general payments, 2019–2025

Across 880 payments — averaging $2446.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi Pasteur Inc.$697K
  • Modernatx, Inc.$421K
  • Sanofi US Services Inc.$281K
  • Vertex$265K
  • Janssen Research & Development, LLC$238K
  • Novavax Inc$169K
  • plus $83K from 6 others

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi Pasteur Inc.65$696,730
Modernatx, Inc.702$420,554
Sanofi US Services Inc.16$281,186
Vertex3$265,390
Janssen Research & Development, LLC34$237,915
Novavax Inc29$168,717
AstraZeneca1$26,700
Shionogi Inc3$23,718
Astrazeneca UK Limited1$23,325
Pfizer24$9,055
Sanofi1$30
Novo Nordisk1$14

How this compares

$2,153,333 in reported general payments places this provider in the 95th percentile of 570 internal medicine providers in Nebraska.

See all internal medicine providers in Nebraska

Medicare billing

Part B allowed, 2024
$88,229
Medicare patients
569
Services billed
594

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →